背景依赖的T-BOX转录因子家族:从生物学到向治疗
Siwen Li1, Xiangyuan Luo1, Mengyu Sun1
1Department of Gastroenterology, Institute of Liver and Gastrointestinal Diseases, Hubei Key Laboratory of Hepato-Pancreato-Biliary Diseases, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, 430030, China.
Cell communication and signaling : CCS
|July 4, 2024
概括
T-BOX转录因子对于发育和免疫力至关重要,但它们在癌症中的上下文依赖作用是复杂的. 了解这些作用是开发有针对性的T-BOX癌症治疗的关键.
科学领域:
- 分子生物学分子生物学
- 发展生物学 发展生物学
- 癌症研究 癌症研究
背景情况:
- T-BOX因子是进化保守的转录因子,涉及生长,发育和免疫.
- 失调的T-BOX因子表达与癌症的发病和进展有关.
- 根据细胞环境和发育阶段,T-BOX因子的功能可能会有很大的变化.
研究的目的:
- 审查T-BOX因素在发育中的生理作用.
- 检查T-BOX因子在各种癌症中的病理作用.
- 讨论T-BOX因子在瘤免疫微环境 (TIME) 中的调节功能,并确定未解决的问题.
主要方法:
- 文献综述和对T-BOX因素现有研究的综合.
- 对T-BOX因子参与正常发育和疾病状态的分析.
- 探索瘤微环境中的T-BOX因子相互作用.
主要成果:
- 在不同的生物环境中,T-BOX因子表现出多样化,有时甚至是对立的功能.
- 它们的失调有助于癌症的发展和进展.
- T-BOX因素显著影响瘤免疫微环境.
结论:
- 对T-BOX因子的上下文依赖作用的全面理解对于癌症治疗至关重要.
- 准T-BOX因子有可能成为新的癌症治疗策略.
- 需要进一步的研究,以充分阐明T-BOX因子在恶性瘤和免疫中的功能.
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
General Transcription Factors
5.2K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
5.2K
Tumor Immunotherapy
509
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
509
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Transcription Factors
75.8K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
75.8K
TGF - β Signaling Pathway
7.3K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.3K


